BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 38495504)

  • 1. Evodiamine Inhibits Colorectal Cancer Growth via RTKs Mediated PI3K/AKT/p53 Signaling Pathway.
    Zheng Q; Jing S; Hu L; Meng X
    J Cancer; 2024; 15(8):2361-2372. PubMed ID: 38495504
    [No Abstract]   [Full Text] [Related]  

  • 2. KIFC3 Promotes Proliferation, Migration, and Invasion in Colorectal Cancer
    Liao H; Zhang L; Lu S; Li W; Dong W
    Front Genet; 2022; 13():848926. PubMed ID: 35812733
    [No Abstract]   [Full Text] [Related]  

  • 3. Berbamine dihydrochloride suppresses the progression of colorectal cancer via RTKs/Akt axis.
    Liu L; Liang D; Zheng Q; Zhao M; Lv R; Tang J; Chen N
    J Ethnopharmacol; 2023 Mar; 303():116025. PubMed ID: 36496042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of evodiamine on PI3K/Akt and MAPK/ERK signaling pathways in pancreatic cancer cells.
    Hong Z; Wang Z; Zhou B; Wang J; Tong H; Liao Y; Zheng P; Jamshed MB; Zhang Q; Chen H
    Int J Oncol; 2020 Mar; 56(3):783-793. PubMed ID: 31922213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A network pharmacology approach and experimental validation to investigate the anticancer mechanism and potential active targets of ethanol extract of Wei-Tong-Xin against colorectal cancer through induction of apoptosis via PI3K/AKT signaling pathway.
    Lin F; Zhang G; Yang X; Wang M; Wang R; Wan M; Wang J; Wu B; Yan T; Jia Y
    J Ethnopharmacol; 2023 Mar; 303():115933. PubMed ID: 36403742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evodiamine inhibits ESCC by inducing M-phase cell-cycle arrest via CUL4A/p53/p21 axis and activating noxa-dependent intrinsic and DR4-dependent extrinsic apoptosis.
    Zhang L; Li L; Chen X; Yuan S; Xu T; Zhao W; Li M; Wang F; Hoffman RM; Jia L
    Phytomedicine; 2023 Jan; 108():154493. PubMed ID: 36265256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ARHGAP9 inhibits colorectal cancer cell proliferation, invasion and EMT via targeting PI3K/AKT/mTOR signaling pathway.
    Sun J; Zhao X; Jiang H; Yang T; Li D; Yang X; Jia A; Ma Y; Qian Z
    Tissue Cell; 2022 Aug; 77():101817. PubMed ID: 35679685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of CPT2 promotes proliferation and inhibits apoptosis through p53 pathway in colorectal cancer.
    Liu F; Li X; Yan H; Wu J; Yang Y; He J; Chen J; Jiang Z; Wu F; Jiang Z
    Cell Signal; 2022 Apr; 92():110267. PubMed ID: 35108639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [LncRNA SNHG11 promotes malignant progression of colorectal cancer cells through the PI3K/Akt/mTOR signaling pathway].
    Tao SN; Liu XC; Wang YY; Yang H
    Zhonghua Yi Xue Za Zhi; 2024 Mar; 104(10):758-765. PubMed ID: 38462356
    [No Abstract]   [Full Text] [Related]  

  • 10. Evodiamine inhibits proliferation and promotes apoptosis of hepatocellular carcinoma cells via the Hippo-Yes-Associated Protein signaling pathway.
    Zhao S; Xu K; Jiang R; Li DY; Guo XX; Zhou P; Tang JF; Li LS; Zeng D; Hu L; Ran JH; Li J; Chen DL
    Life Sci; 2020 Jun; 251():117424. PubMed ID: 32057900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evodiamine Exerts Anticancer Effects Against 143B and MG63 Cells Through the Wnt/β-Catenin Signaling Pathway.
    Yang S; Chen J; Tan T; Wang N; Huang Y; Wang Y; Yuan X; Zhang P; Luo J; Luo X
    Cancer Manag Res; 2020; 12():2875-2888. PubMed ID: 32425601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of colorectal cancer tumorigenesis by ursolic acid and doxorubicin is mediated by targeting the Akt signaling pathway and activating the Hippo signaling pathway.
    Hu D; Meng RY; Nguyen TV; Chai OH; Park BH; Lee JS; Kim SM
    Mol Med Rep; 2023 Jan; 27(1):. PubMed ID: 36382656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long noncoding RNA SNHG14 accelerates cell proliferation, migration, invasion and suppresses apoptosis in colorectal cancer cells by targeting miR-944/KRAS axis through PI3K/AKT pathway.
    Pei Q; Liu GS; Li HP; Zhang Y; Xu XC; Gao H; Zhang W; Li T
    Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9871-9881. PubMed ID: 31799655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Root extract of Hemsleya amabilis Diels suppresses renal cell carcinoma cell growth through inducing apoptosis and G
    Li K; You G; Jiang K; Wang R; Li W; Meng Y; Fang Y; Chen W; Zhu G; Song J; Wang W; Su H; Hu B; Sun F; Jia Z; Li C; Zhu J
    J Ethnopharmacol; 2024 Jan; 318(Pt B):117014. PubMed ID: 37557938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evodiamine Induces Apoptosis in SMMC-7721 and HepG2 Cells by Suppressing NOD1 Signal Pathway.
    Guo XX; Li XP; Zhou P; Li DY; Lyu XT; Chen Y; Lyu YW; Tian K; Yuan DZ; Ran JH; Chen DL; Jiang R; Li J
    Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30384473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evodiamine inhibits the proliferation of human osteosarcoma cells by blocking PI3K/Akt signaling.
    Meng ZJ; Wu N; Liu Y; Shu KJ; Zou X; Zhang RX; Pi CJ; He BC; Ke ZY; Chen L; Deng ZL; Yin LJ
    Oncol Rep; 2015 Sep; 34(3):1388-96. PubMed ID: 26135006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pyrroline-5-Carboxylate Reductase-2 Promotes Colorectal Cancer Progression via Activating PI3K/AKT/mTOR Pathway.
    Yin F; Huang X; Xuan Y
    Dis Markers; 2021; 2021():9950663. PubMed ID: 34512817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ginsenoside Rg3 inhibits cell growth, migration and invasion in Caco-2 cells by downregulation of lncRNA CCAT1.
    Li J; Qi Y
    Exp Mol Pathol; 2019 Feb; 106():131-138. PubMed ID: 30633886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evodiamine Induces Apoptosis and Inhibits Migration of HCT-116 Human Colorectal Cancer Cells.
    Zhao LC; Li J; Liao K; Luo N; Shi QQ; Feng ZQ; Chen DL
    Int J Mol Sci; 2015 Nov; 16(11):27411-21. PubMed ID: 26580615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evodiamine inhibits migration and invasion by Sirt1-mediated post-translational modulations in colorectal cancer.
    Zhou P; Li XP; Jiang R; Chen Y; Lv XT; Guo XX; Tian K; Yuan DZ; Lv YW; Ran JH; Li J; Chen DL
    Anticancer Drugs; 2019 Jul; 30(6):611-617. PubMed ID: 30789361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.